Spread of novel expanded-spectrum β-lactamases in enterobacteriaceae in a university hospital in the Paris area, France

28Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In 2002, 28 non-duplicate enterobacterial isolates producing extended-spectrum β-lactamases (ESBLs) were collected from infected patients at the Bicêtre Hospital in Paris, France. Escherichia coli was the predominant ESBL-positive enterobacterial species, comprising ten (36%) of the isolates. CTX-M enzymes (CTX-M-3, CTX-M-10, CTX-M-14 and CTX-M-15) were produced by 11 (39%) of the isolates (six E. coli, two Enterobacter cloacae, one Enterobacter aerogenes, one Proteus mirabilis and one Citrobacter freundii). Other ESBLs, such as VEB-1 and PER-1, were also detected, but less frequently. © 2005 Copyright by the European Society of Clinical Microbiology and Infectious Diseases.

Cite

CITATION STYLE

APA

Lartigue, M. F., Fortineau, N., & Nordmann, P. (2005). Spread of novel expanded-spectrum β-lactamases in enterobacteriaceae in a university hospital in the Paris area, France. Clinical Microbiology and Infection, 11(7), 588–591. https://doi.org/10.1111/j.1469-0691.2005.01172.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free